Receptor tyrosine kinase inhibitor Sunitinib as novel immunotherapy to inhibit myeloid-derived suppressor cells for treatment of endometriosis
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA625083
下载链接
链接失效反馈官方服务：
资源简介：
Sunitinib inhibited endometriotic lesion by promoting peritoneal fluid MDSCs maturation and inhibiting its immunosuppressive functions. It changed the immune microenvironment and inhibited development of endometriosis.
创建时间：
2020-04-13
